Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for androgenetic alopecia
ACTRN12613000821796Phase 4Completed
- Sponsor
- Ponsonby Cosmetic Medical Clinic
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Ponsonby Cosmetic Medical Clinic. Primary endpoint: Hair bulk. Started Jan 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ACTRN12613000821796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000821796.